Profile
Lumerate is launching a new software brand called BioBackers - the intelligence platform for life science fundraising. BioBackers delivers curated, near-real-time investor insights that helps therapeutics-focused life science companies discover and engage investors whose focus aligns with their venture's profile and fundraising goals, to help them efficiently secure capital and advance their therapeutic pipeline.
Event details
Date: January 12 - 14, 2026
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
21 in total
-
20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for… -
BioBox is a data integration and decision-intelligence platform for drug discovery. It helps biopharma bring… -
Eurofins CDMO Alphora develops and… -
Fibra turns everyday underwear into a real-time reproductive health platform — capturing critical biomarker data… -
For over two decades, Toronto area-based GL CHEMTEC has been dedicated to delivering innovative… -
HDAX Therapeutics, a biotechnology company pioneering a novel approach to target… -
ImmunoBiochem is a pharma-partnered biotech developing novel bioconjugate therapeutics, such as… -
Iseehear Inc. is a leading provider of comprehensive IT solutions for… -
Kapoose Creek Bio is pioneering a new generation of therapeutics by fusing nature’s untapped chemistry with… -
Lumerate is launching a new software brand called BioBackers - the intelligence platform for life science… -
Medicenna is a clinical-stage immunotherapy company pioneering best- and/or first-in-class Superkines -… -
Noa Therapeutics has developed a proprietary NRF2-… -
Nucro-Technics is a GLP- and… -
Paradox Immunotherapeutics is a biotech addressing the global burden of protein misfolding diseases—devastating… -
Pattern Pharma’s patent-protected immunotherapeutic, PPI-100, mobilizes innate immunity by targeting… -
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. PQ… -
QurCan Therapeutics is advancing the next wave of genetic medicines for CNS… -
Rhythm Biotherapeutics develops first-in-class, heart-derived exosome therapeutics to prevent atrial fibrillation… -
Spiderwort is a platform biomaterials company developing a suite of cellulose-based scaffolds for use in a number… -
Tenomix’s mission is to develop novel technologies that target inefficiencies in the pathology workflow, optimize… -
Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide…